Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Temozolomide: phase II efficacy and tolerability data in patients with high-grade glioma

Oct. 31, 1997

Takeda discovers new Taxol-like compound

Oct. 31, 1997

HMR discloses azasteroids for estrogen/androgen-mediated disorders

Oct. 31, 1997

IntraBiotics codevelops IB-367 with Pharmacia & Upjohn

Oct. 31, 1997

Angiogenesis-inhibitory peptides available for licensing from NIH

Oct. 31, 1997

BE-52440A and BE-52440B: novel antitumor antibiotics reported in patent literature

Oct. 31, 1997

Inflammatory and angiogenic protein-related technology available for licensing

Oct. 30, 1997

Neovascularization inhibitors disclosed by Takeda

Oct. 30, 1997

Bicalutamide + LHRH-A vs. flutamide + LHRH-A for metastatic prostate cancer

Oct. 29, 1997

Banyu discloses protein farnesyltransferase inhibitors

Oct. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...